An observational study in Practice Guideline of Erythrocyte Transfusion in Preterm Infant, sponsored by Centre Hospitalier Universitaire, Amiens. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2018-07-26.
Sponsored by Centre Hospitalier Universitaire, Amiens · Observational
The indications that motivated the decision to transfuse (or not) were analyzed to verify compliance with HAS recommendations. Medical records from 57 premature infants \< 32 weeks hospitalized between 2016 -2017 were retrospectively analysed, especially all the events related to monitoring of hemoglobin level and RBC transfusions during the first month of life. The criteria (postnatal age, rate of haemoglobin, type of breathing assistance, oxygen needing, medullary regeneration) on which rely the decision process in the HAS algorithm for the RBC transfusion were also considered, as well as the final decision actually adopted for each case (transfused/ not transfused). All this made it possible to determine the kappa coefficient for evaluation of agreement with HAS new guidelines in the investigator's medical staff.
2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.
This study's enrollment of 57 is below the median of 112 across 777 observational studies indexed under Premature Birth.
Browse Premature Birth studies →Centre Hospitalier Universitaire, Amiens is the lead sponsor of 576 studies on the registry; 178 are open to participants now.
Counted across the registry records on this site, refreshed daily.
preterm infant hospitalized in Amiens School hospital (CHU Amiens-Picardie) between October 2016 and April 2017 during the first month of life
Exclusion Criteria:
Proportion of events managed in accordance with the HAS guidelines for RBC tranfusion in the very preterm infants (< 32 weeks).
Time frame: during the first month of life
Evolution of the haemoglobin level (Hematocrit)
from the birth until the day 28, with respect to postnatal age and the gestational age
Time frame: during the first month of life
volume of blood loss
Time frame: during the first month of life
number of transfusion during the first month of life
Time frame: during the first month of life
correlation between the number of transfusion and the volume of blood loss
Time frame: during the first month of life
Analyses of neonatal morbidity associated with blood transfusion in premature neonates under 32 weeks of pregnancy
Neonatal morbidity are patent ductus arterious, intraventricular hemorrhage, chronic lung disease, necrotizing enterocolitis, retinopathy of the prematurity, materno-fetal infection and the late-onset infection, and diverse hematological practices
Time frame: during the first month of life
This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire, Amiens